Emicizumab treatment in hemophilia A with inhibitors. A case report and cost-minimization analysis of a non-responder to conventional treatment patient

被引:0
|
作者
Martinez Garcia, M. F. [1 ]
Fernandez Caballero, M. [1 ]
Juarez Gimenez, J. C. [2 ]
Serna Pareja, A. [1 ]
Cerda Sabater, M. [1 ]
Johansson, E. [1 ]
Alvarez Martinez, E. [1 ]
Fernandez Sarmiento, C. [1 ]
Bosch Albareda, F. [1 ]
Santamaria Ortiz, A. [1 ]
机构
[1] Vall dHebron Univ Hosp, Hemophilia Unit, Hematol Dept, Barcelona, Spain
[2] Vall dHebron Univ Hosp, Hemophilia Unit, Dept Hosp Pharm, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P191
引用
收藏
页码:131 / 131
页数:1
相关论文
共 50 条
  • [1] A cost minimization model for the treatment of patients with hemophilia A and high titer inhibitors.
    Bohn, RL
    Putnam, KG
    Ewenstein, BM
    Winkelmayer, WC
    Avorn, J
    BLOOD, 2002, 100 (11) : 222A - 222A
  • [2] COST-MINIMIZATION ANALYSIS OF DAMOCTOCOG ALFA PEGOL WITH THE TREATMENT OF HEMOPHILIA A IN TURKEY
    Gursoy, K.
    Saribal, B.
    Saylan, M.
    VALUE IN HEALTH, 2022, 25 (12) : S60 - S60
  • [3] EMICIZUMAB TREATMENT IN A PATIENT WITH ACQUIRED HEMOPHILIA A - CLINICAL CASE REPORT
    Rahuoja, K.
    Ross, M.
    Varik, M.
    Pikta, M.
    HAEMOPHILIA, 2023, 29 : 112 - 112
  • [4] EMICIZUMAB AND BYPASSING TREATMENT FOR ABOVE KNEE AMPUTATION IN A HEMOPHILIA A PATIENT WITH INHIBITORS - CLINICAL CASE REPORT
    Ross, M.
    Rahuoja, K.
    Pikta, M.
    Varik, M.
    HAEMOPHILIA, 2023, 29 : 119 - 119
  • [5] Cost-minimization analysis of recombinant factor VIII Fc versus emicizumab for treating patients with hemophilia A without inhibitors in Europe
    Mancuso, Maria Elisa
    Castaman, Giancarlo
    Pochopien, Michal
    Aballea, Samuel
    Drzewiecka, Aleksandra
    Hakimi, Zalmai
    Nazir, Jameel
    Fatoye, Francis
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 1068 - 1075
  • [6] Cost-minimization analysis of pneumonia treatment in Indonesia
    Wardati, Yulia
    Sinuraya, Rano K.
    Kusuma, Arif S. W.
    Subarnas, Anas
    Diantini, Ajeng
    Suwantika, Auliya A.
    PHARMACIA, 2023, 70 (02) : 391 - 394
  • [7] Emicizumab Use in Treatment of Acquired Hemophilia A: A Case Report
    Al-Banaa, Kadhim
    Alhillan, Alsadiq
    Hawa, Fadi
    Mahmood, Raai
    Zaki, Ahmed
    El Abdallah, Mohamad
    ELJack, Ammar
    Zimmerman, Jonathan
    Musa, Faisal
    AMERICAN JOURNAL OF CASE REPORTS, 2019, 20 : 1046 - 1048
  • [8] EMICIZUMAB TREATMENT IN PATIENT WITH ACQUIRED HEMOPHILIA CAN BE A RELAY TO BYPASSING AGENTS: A CASE REPORT
    Toutain, I. Martin
    Launois, A.
    Lambert, J.
    Longval, T.
    Merabet, F.
    Jaidi, R.
    LeDore, S.
    Ferre, E.
    De Raucourt, E.
    Flaujac, C.
    HAEMOPHILIA, 2023, 29 : 98 - 98
  • [9] Cost-minimization analysis for the treatment of the hyperthyreosis: Strumaresection compared to radioiodine treatment
    Dietlin, M
    Geckle, L
    Overbeck, T
    Moka, D
    Bausch, V
    Troche, CJ
    Lauterbach, K
    Schicha, H
    NUKLEARMEDIZIN, 1997, 36 (05) : 150 - 156
  • [10] A cost-minimization analysis of alternative treatment strategies for achalasia
    Imperiale, TF
    O'Connor, JB
    Vaezi, MF
    Richter, JE
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (10) : 2737 - 2745